Back
Vermilion Energy Vs. Janux Therapeutics Industry Stock Comparison
Sell
50
VET
Vermilion Energy
Last Price:
10.20
Seasonality Move:
8.88%
Sell
34
JANX
Janux Therapeutics
Last Price:
59.86
Seasonality Move:
133.13%
Sell
50
Vermilion Energy (VET)
is a Sell
Is Vermilion Energy a Buy, Sell or Hold?
- The current Vermilion Energy [VET] share price is $10.14. The Score for VET is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- VET is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $40.18. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VET Stock Price Chart
What is Vermilion Energy's stock price today?
-
The Vermilion Energy share price today is $10.14
The current trend is moderately bullish and VET is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $40.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
VET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 52.02 | Buy |
Chaikin Money Flow: | -69232 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.5 - 10.34) | Buy |
Bollinger Bands (100): | (9.47 - 10.51) | Buy |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.77 | Sell |
Relative Strength Index (14 RSI): | 27.24 | Sell |
Chaikin Money Flow: | -1691426 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.18 - 54.98) | Sell |
Bollinger Bands (100): | (41.61 - 51.41) | Sell |
VET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.37 | Sell |
20-day SMA: | 10.04 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 10.84 | Sell |
8-day EMA: | 10.23 | Sell |
20-day EMA: | 10.1 | Buy |
50-day EMA: | 9.99 | Buy |
200-day EMA: | 10.78 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.8 | Sell |
20-day SMA: | 50.2 | Sell |
50-day SMA: | 49.69 | Sell |
200-day SMA: | 44.62 | Sell |
8-day EMA: | 46.1 | Sell |
20-day EMA: | 48.65 | Sell |
50-day EMA: | 48.98 | Sell |
200-day EMA: | 41.57 | Sell |
Vermilion Energy Earnings Growth & VET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.68 per share, and an increase next year of $0.59 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.76 per share.
Vermilion Energy Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |